Artemisinin clinical trials
How each study uses artemisinin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Artemisinin
- 4
Studies by the year they started
6 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 5
Johns Hopkins University (1) · Mateon Therapeutics (1) · Ifakara Health Institute (1) · Beijing HuiLongGuan Hospital (1) · Sheppard Pratt Health System (1) · Princess Nourah Bint Abdulrahman University (1)
Often tested with
Tested in the same studies.
Naphthoquine (1) · Artesunate (1)
Studies
Open first, then newest update. How each study uses artemisinin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Evaluating the Efficacy of Artesunate in Adults With Mild Symptoms of COVID-19WithdrawnPhase 2Princess Nourah Bint Abdulrahman UniversityNCT04387240Written as Artemisinin / ArtesunateHow we know
- Intra-Anally Administered Artesunate in Patients With High-Grade Anal Intraepithelial Neoplasia (AIN 2/3)CompletedPhase 1Johns Hopkins UniversityNCT03100045Written as Artesunate SuppositoriesHow we know
- A Study to Evaluate the Safety and Efficacy of Artemisinin- a Herbal Supplement on COVID-19 SubjectsCompletedPhase 4Mateon TherapeuticsNCT05004753Written as ArtemisininHow we know
- Safety, Tolerability, Pharmacokinetics and Efficacy of ARCOCompletedPhase 4Ifakara Health InstituteNCT01930331Written as artemisinin/naphthoquineHow we know
- Artemisinin With Risperidone for First-Episode and Drug-Naive SchizophreniaCompletedPhase 3Beijing HuiLongGuan HospitalNCT01391403Written as ArtemisininHow we know
- Artemisinin to Reduce The Symptoms of SchizophreniaCompletedNot applicableSheppard Pratt Health SystemNCT00753506Written as ArtemisininHow we know
Given beside what is tested · 1 — artemisinin is usual care or a partner of the new treatment
Codes
What other systems call artemisinin · ClinicalTrials.gg INT002948
- MeSH (NLM) C031327artemisininConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 9RMU91N5K2ARTEMISININConfirmed FDA, NLM, Wikidata
- RxNorm 2367409One source FDA
- Wikidata Q426921artemisininConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C78093ArtemisininOne source FDA
- DrugBank DB13132One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C031327 | artemisinin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 9RMU91N5K2 | ARTEMISININ | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2367409 | — | One source FDA |
| Wikidata | Q426921 | artemisinin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C78093 | Artemisinin | One source FDA |
| DrugBank | DB13132 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.